KSHV is an opportunistic pathogen that rarely affects individuals with normal immune systems.
KSHV是一种条件性致病病毒，它很少影响免疫系统正常的个体。
These observations provide evidence that therapy designed to target cells with lytic KSHV replication has activity in KSHV-MCD.
这些观察提供的证据表明，设计针对细胞的KSHV复制裂解疗法对K SHV - MCD有效。
Additionally, this combination treatment reduced KSHV viral loads and circulating levels of human and viral IL-6 in these patients.
此外，这一联合治疗还可降低这些患者的KSHV病毒载量和人及病毒IL - 6循环水平。
This, he says, is important in finding or designing drugs that can be specifically used against KSHV, and potentially, other virus-associated cancers.
他说这在寻找和设计特异性抗kshv和潜在的其它的病毒相关性肿瘤药物时有重要作用。
It is thought that viral lytic proteins expressed in KSHV-MCD contribute to cytokine dysregulation, paracrine signaling, and the pathogenesis of this disease.
目前认为KSHV - MCD所表达的病毒裂解蛋白参与了细胞因子调节异常、旁分泌信号传导和疾病的发生。
It is thought that viral lytic proteins expressed in KSHV-MCD contribute to cytokine dysregulation, paracrine signaling, and the pathogenesis of this disease.
目前认为KSHV - MCD所表达的病毒裂解蛋白参与了细胞因子调节异常、旁分泌信号传导和疾病的发生。
应用推荐